NLRP3 and neoplasm: Similarly, after NLRP3 inflammasome activity was inhibited, IL-1β secretion decreased, attenuating inflammatory cascades in the TME, which helps reduce pro-tumorigenic inflammation in the tumor microenvironment (Chen et al., 2018).